JP2011518856A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011518856A5 JP2011518856A5 JP2011506677A JP2011506677A JP2011518856A5 JP 2011518856 A5 JP2011518856 A5 JP 2011518856A5 JP 2011506677 A JP2011506677 A JP 2011506677A JP 2011506677 A JP2011506677 A JP 2011506677A JP 2011518856 A5 JP2011518856 A5 JP 2011518856A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pyridin
- alkoxy
- imidazo
- ylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08155405 | 2008-04-29 | ||
| EP08155405.7 | 2008-04-29 | ||
| PCT/EP2009/055066 WO2009133070A1 (en) | 2008-04-29 | 2009-04-27 | Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011518856A JP2011518856A (ja) | 2011-06-30 |
| JP2011518856A5 true JP2011518856A5 (cg-RX-API-DMAC7.html) | 2012-06-07 |
| JP5507543B2 JP5507543B2 (ja) | 2014-05-28 |
Family
ID=40043988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011506677A Expired - Fee Related JP5507543B2 (ja) | 2008-04-29 | 2009-04-27 | アクチビン様受容体キナーゼ(alk4またはalk5)阻害剤としてのイミダゾ−ピリジン誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9079897B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2307402B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5507543B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20100130226A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102015691B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009242145B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0911490A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2722131A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201001687A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2399175T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2010011867A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2307402T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2307402E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009133070A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2531500B1 (en) | 2010-02-05 | 2018-01-24 | Merck Patent GmbH | Hetaryl-[1,8]naphthyridine derivatives |
| BR112012019561A2 (pt) | 2010-02-22 | 2019-09-24 | Merck Patent Gmbh | hetarilamino naftiridinas |
| WO2011146287A1 (en) | 2010-05-20 | 2011-11-24 | Takeda Pharmaceutical Company Limited | Pyrazolo[4,3-b]pyridine-7-amine inhibitors of alk5 |
| US8871744B2 (en) | 2010-07-21 | 2014-10-28 | B & G Partyers, LLC | Compounds and methods for selectively targeting tumor-associated mucins |
| ES2962147T3 (es) | 2010-11-08 | 2024-03-15 | Sk Chemicals Co Ltd | Resina de ácido poliláctico, procedimiento de preparación de la misma, y película de embalaje que comprende la misma |
| US20140088174A1 (en) * | 2011-04-05 | 2014-03-27 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Compounds and methods for altering activin receptor-like kinase signaling |
| CN105431148A (zh) | 2013-03-07 | 2016-03-23 | 加利菲亚生物公司 | 混合谱系激酶抑制剂及治疗方法 |
| EP3283475B1 (en) * | 2015-04-16 | 2019-10-16 | Merck Patent GmbH | 3-(1h-benzimidazol-2-yl)-1h-pyridin-2-one derivatives |
| HK1257171A1 (zh) * | 2015-09-23 | 2019-10-18 | Dana Farber Cancer Institute, Inc. | 间变性淋巴瘤激酶(alk)和丝氨酸富集蛋白激酶 (sppk)的抑制剂及其使用方法 |
| RU2642456C2 (ru) * | 2016-06-29 | 2018-01-25 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Ярославский государственный университет им. П.Г. Демидова" | Способ получения N-арилзамещенных 3H-имидазо[4,5-b]пиридинов |
| US11466003B2 (en) | 2016-07-29 | 2022-10-11 | Shanghai Yingli Pharmaceutical Co., Ltd | Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof |
| CN106831770A (zh) * | 2017-03-13 | 2017-06-13 | 牡丹江医学院 | 一种药物组合物及其用于治疗肝硬化的用途 |
| CN110066277B (zh) | 2018-01-24 | 2021-07-23 | 上海璎黎药业有限公司 | 芳香杂环取代烯烃化合物、其制备方法、药物组合物和应用 |
| CN110066276B (zh) | 2018-01-24 | 2020-09-18 | 上海璎黎药业有限公司 | 芳香杂环化合物、其中间体、制备方法、药物组合物和应用 |
| WO2020012357A1 (en) * | 2018-07-10 | 2020-01-16 | Integral Biosciences Pvt. Ltd. | Heterocyclic compounds and methods of use |
| LT3860998T (lt) | 2018-10-05 | 2024-06-25 | Annapurna Bio Inc. | Junginiai ir kompozicijos, skirti gydyti būkles, susijusias su apj receptoriaus aktyvumu |
| CN115052663B (zh) | 2020-01-08 | 2026-06-09 | 辛瑟斯治疗股份有限公司 | Alk5抑制剂缀合物及其用途 |
| US20230174620A1 (en) | 2020-04-28 | 2023-06-08 | Acceleron Pharma Inc. | Actrii proteins and use in treating post-capillary pulmonary hypertension |
| EP4182323B1 (en) | 2020-07-15 | 2024-04-24 | Chiesi Farmaceutici S.p.A. | Pyrido oxazine amino derivatives as alk5 inhibitors |
| EP4182322B1 (en) | 2020-07-15 | 2024-04-24 | Chiesi Farmaceutici S.p.A. | Pyrido oxazine derivatives as alk5 inhibitors |
| PT4182308T (pt) | 2020-07-15 | 2024-12-04 | Chiesi Farm Spa | Derivados de piridazinil amino como inibidores de alk5 |
| WO2022136221A1 (en) | 2020-12-23 | 2022-06-30 | Chiesi Farmaceutici S.P.A. | Pyrido oxazine derivatives as alk5 inhibitors |
| CA3232178A1 (en) | 2021-09-21 | 2023-03-30 | Daniela PIZZIRANI | Pyridazinyl amino derivatives as alk5 inhibitors |
| US20250270215A1 (en) | 2022-04-27 | 2025-08-28 | Chiesi Farmaceutici S.P.A. | Imidazole derivatives as alk5 inhibitors |
| WO2024258967A1 (en) | 2023-06-13 | 2024-12-19 | Synthis Therapeutics, Inc. | Anti-cd5 antibodies and their uses |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK40192D0 (da) * | 1992-03-26 | 1992-03-26 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
| GB9921150D0 (en) * | 1999-09-07 | 1999-11-10 | Merck Sharp & Dohme | Therapeutic agents |
| GB0217783D0 (en) * | 2002-07-31 | 2002-09-11 | Glaxo Group Ltd | Compounds |
| WO2005023246A1 (en) * | 2003-09-04 | 2005-03-17 | Aventis Pharmaceuticals Inc. | Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
| KR101229647B1 (ko) * | 2004-09-03 | 2013-02-05 | 메르크 세로노 에스.에이. | 피리딘 메틸렌 아조리디논 및 포스포이노시타이드 저해제의용도 |
| CA2657227A1 (en) * | 2006-07-14 | 2008-01-17 | Novartis Ag | Pyrimidine derivatives as alk-5 inhibitors |
| BRPI0718266A2 (pt) * | 2006-10-30 | 2014-01-07 | Novartis Ag | Compostos heterocíclicos como agentes anti-inflamatórios. |
-
2009
- 2009-04-27 EP EP09738114A patent/EP2307402B1/en not_active Not-in-force
- 2009-04-27 JP JP2011506677A patent/JP5507543B2/ja not_active Expired - Fee Related
- 2009-04-27 AU AU2009242145A patent/AU2009242145B2/en not_active Ceased
- 2009-04-27 ES ES09738114T patent/ES2399175T3/es active Active
- 2009-04-27 PT PT97381149T patent/PT2307402E/pt unknown
- 2009-04-27 CA CA2722131A patent/CA2722131A1/en not_active Abandoned
- 2009-04-27 WO PCT/EP2009/055066 patent/WO2009133070A1/en not_active Ceased
- 2009-04-27 CN CN200980115503.0A patent/CN102015691B/zh not_active Expired - Fee Related
- 2009-04-27 EA EA201001687A patent/EA201001687A1/ru unknown
- 2009-04-27 MX MX2010011867A patent/MX2010011867A/es active IP Right Grant
- 2009-04-27 BR BRPI0911490A patent/BRPI0911490A2/pt not_active IP Right Cessation
- 2009-04-27 US US12/935,405 patent/US9079897B2/en not_active Expired - Fee Related
- 2009-04-27 PL PL09738114T patent/PL2307402T3/pl unknown
- 2009-04-27 KR KR1020107024212A patent/KR20100130226A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jin et al. | Discovery of N-((4-([1, 2, 4] Triazolo [1, 5-a] Pyridin-6-Yl)-5-(6-Methylpyridin-2-Yl)-1 H-Imidazol-2-Yl) methyl)-2-Fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent | |
| KR102566924B1 (ko) | 케모카인 수용체 조절제 및 이의 용도 | |
| JP2021063119A (ja) | 噴霧乾燥製剤 | |
| Ferrara et al. | Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy | |
| Castelino et al. | Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management | |
| KR102350088B1 (ko) | 키나제 조절, 및 그에 대한 적응증을 위한 화합물 및 방법 | |
| JP2014139226A5 (cg-RX-API-DMAC7.html) | ||
| JP2014513110A5 (cg-RX-API-DMAC7.html) | ||
| JP2006502112A5 (cg-RX-API-DMAC7.html) | ||
| RU2016137181A (ru) | Противофиброзные пиридиноны | |
| RU2007146390A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
| JP2014518880A5 (cg-RX-API-DMAC7.html) | ||
| JP2018515570A (ja) | Braf−v600関連疾患の治療に使用するためのplx−8394またはplx−7904 | |
| JP6892381B2 (ja) | 多発性骨髄腫を治療するための薬物の組み合わせ | |
| JP2013510125A5 (cg-RX-API-DMAC7.html) | ||
| CN103214484A (zh) | 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶 | |
| CN105142624A (zh) | 非选择性激酶抑制剂 | |
| JP2013510124A5 (cg-RX-API-DMAC7.html) | ||
| JP2016516791A5 (cg-RX-API-DMAC7.html) | ||
| JP2019503337A5 (cg-RX-API-DMAC7.html) | ||
| WO2012085815A1 (en) | Bi-heteroaryl compounds as vps34 inhibitors | |
| JP2010516701A5 (cg-RX-API-DMAC7.html) | ||
| JP2017520613A5 (cg-RX-API-DMAC7.html) | ||
| JP2014141515A (ja) | Vegf促進性血管新生過程の強力なモジュレーターとしての5イミダゾキノリン誘導体およびピリミジン誘導体 | |
| JP2008517913A5 (cg-RX-API-DMAC7.html) |